OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent advances in the treatment of Charcot‐Marie‐Tooth neuropathies
Alessandra Bolino, Maurizio D’Antonio
Journal of the Peripheral Nervous System (2023) Vol. 28, Iss. 2, pp. 134-149
Open Access | Times Cited: 23

Showing 23 citing articles:

PMP22 duplication dysregulates lipid homeostasis and plasma membrane organization in developing human Schwann cells
Robert Prior, Alessio Silva, Tim Vangansewinkel, et al.
Brain (2024) Vol. 147, Iss. 9, pp. 3113-3130
Open Access | Times Cited: 5

Disease Progression in Charcot‐Marie‐Tooth Disease Type 4B (CMT4B) Associated With Mutations in Myotubularin‐Related Proteins 2 and 13
Alessandro Bertini, Mary M. Reilly, Chiara Pisciotta, et al.
European Journal of Neurology (2025) Vol. 32, Iss. 2
Open Access

Research focus and theme trend on Charcot–Marie–Tooth disease since 2000: a bibliometric analysis
Shimiao Dai, Junying Zhu, Aolei Yang, et al.
The Egyptian Journal of Neurology Psychiatry and Neurosurgery (2025) Vol. 61, Iss. 1
Open Access

BIN1 reduction ameliorates DNM2 -related Charcot–Marie–Tooth neuropathy
Marie Goret, Morgane Thomas, Evelina Edelweiss, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 10
Open Access

Activation of XBP1s attenuates disease severity in models of proteotoxic Charcot-Marie-Tooth type 1B
Thierry Touvier, Francesca A Veneri, Anke Claessens, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2

Molecular mechanisms and therapeutic strategies for neuromuscular diseases
Alberto A. Zambon, Falzone Yuri Matteo, Bolino Alessandra, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 2

Parent‐proxy pediatric CMT quality of life outcome measure: Validation of the Italian version
Federica Rachele Danti, Emanuela Pagliano, Davide Pareyson, et al.
Journal of the Peripheral Nervous System (2024) Vol. 29, Iss. 1, pp. 107-110
Open Access | Times Cited: 1

Will new investigational drugs change the way we treat Charcot-Marie-Tooth disease?
Amedeo De Grado, Chiara Pisciotta, Paola Saveri, et al.
Expert Opinion on Investigational Drugs (2024) Vol. 33, Iss. 7, pp. 653-656
Open Access | Times Cited: 1

Navigating the Landscape of CMT1B: Understanding Genetic Pathways, Disease Models, and Potential Therapeutic Approaches
Mary Kate McCulloch, Fatemeh Mehryab, Afrooz Rashnonejad
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9227-9227
Open Access | Times Cited: 1

Physical exercise halts further functional decline in an animal model for Charcot–Marie–Tooth disease 1X at an advanced disease stage
Dennis Klein, Maria Grijalva Yépez, Rudolf Martini
Journal of the Peripheral Nervous System (2024)
Open Access | Times Cited: 1

Novel biallelic nonsense mutation in IGHMBP2 gene linked to neuropathy (CMT2S): A comprehensive clinical, genetic and bioinformatic analysis of a Turkish patient with literature review
Cüneyd Yavaş, Mustafa Doğan, Bilge Özgör, et al.
Brain and Development (2024) Vol. 47, Iss. 1, pp. 104313-104313
Closed Access | Times Cited: 1

Cytokine-Induced Neurogenesis in Charcot-Marie-Tooth neuropathy with Connexin 32 Gene Mutation
Takuji Shirasawa
Mathews Journal of Case Reports (2023) Vol. 8, Iss. 7
Open Access | Times Cited: 2

In Vivo Ultrafast Doppler Imaging Combined with Confocal Microscopy and Behavioral Approaches to Gain Insight into the Central Expression of Peripheral Neuropathy in Trembler-J Mice
Mariana Martínez Barreiro, Lucía Vázquez Alberdi, Lucila De León, et al.
Biology (2023) Vol. 12, Iss. 10, pp. 1324-1324
Open Access | Times Cited: 2

New perspectives for gene therapy of the X-linked form of Charcot-Marie-Tooth disease
Rafel Balada, Mario Bortolozzi
Molecular Therapy — Methods & Clinical Development (2024) Vol. 32, Iss. 1, pp. 101184-101184
Open Access

Identification of a Novel Homozygous Mutation in MTMR2 Gene Causes Very Rare Charcot–Marie–Tooth Disease Type 4B1
Nan Du, Xiaolei Wang, Zhaohui Wang, et al.
The Application of Clinical Genetics (2024) Vol. Volume 17, pp. 71-84
Open Access

Pharmacologically increasing cGMP improves proteostasis and reduces neuropathy in mouse models of CMT1
Seth M. Moore, Joseph Gawron, Mckayla Stevens, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access

AAV-mediated editing of PMP22 rescues Charcot-Marie-Tooth disease type 1A features in patient-derived iPS Schwann cells
Yuki Yoshioka, Juliana Bosso Taniguchi, Hidenori Homma, et al.
Communications Medicine (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 1

Targeting muscle to treat Charcot-Marie-Tooth disease
David Villarroel‐Campos, James N. Sleigh
Neural Regeneration Research (2023) Vol. 19, Iss. 8, pp. 1653-1654
Open Access | Times Cited: 1

Biallelic Loss-of-Function Variants in BICD1 Are Associated with Peripheral Neuropathy and Hearing Loss
Yoel Hirsch, Wendy K. Chung, Sergey S. Novoselov, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 8897-8897
Open Access

Page 1

Scroll to top